Medicine & Life Sciences
Acute Myeloid Leukemia
100%
Precursor Cell Lymphoblastic Leukemia-Lymphoma
76%
Survival
63%
Cell Transplantation
59%
Transplants
56%
Allogeneic Cells
54%
Hematopoietic Stem Cell Transplantation
47%
Leukemia
38%
Stem Cell Transplantation
37%
Bone Marrow
36%
Myelodysplastic Syndromes
36%
Graft vs Host Disease
30%
Transplantation
27%
Multiple Myeloma
27%
Recurrence
27%
Unrelated Donors
25%
Therapeutics
25%
Primary Myelofibrosis
24%
Hematopoietic Stem Cells
24%
Homologous Transplantation
23%
Tissue Donors
21%
Drug Therapy
20%
Cytogenetics
19%
Stem Cells
18%
Cytarabine
18%
Confidence Intervals
16%
Philadelphia Chromosome
16%
Mortality
15%
Melphalan
15%
Siblings
15%
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
15%
Mutation
15%
Peripheral Blood Stem Cells
14%
Peripheral Blood Stem Cell Transplantation
13%
Bone Marrow Transplantation
13%
Immunoglobulin Light-chain Amyloidosis
12%
venetoclax
12%
Protein-Tyrosine Kinases
12%
Karyotype
11%
Neoplasms
11%
Progression-Free Survival
11%
Leukemia, Myelomonocytic, Chronic
11%
fludarabine
10%
Hematologic Neoplasms
10%
Busulfan
9%
Induction Chemotherapy
9%
Young Adult
9%
Daunorubicin
9%
GATA2 Deficiency
9%